Tradestie Institutional Equity Comparison Engine · Market Close Nov 20, 2026

BFLY.WS vs GEHC: Which Stock Is the Better Buy Now?

Deterministic 6-pillar institutional evaluation across valuation multiples, TTM & multi-year operating margins, cash generation, options IV skew, and supply-chain moat.

GEHC Wins Head-to-Head Institutional Verdict (6–0 across 6 Pillars · 10–0 Matrix Metrics)

GEHC Overall Winner 6-Pillar Tally: BFLY.WS 0 – 6 GEHC Matrix Metrics: BFLY.WS 0 – 10 GEHC

As of Nov 20, 2026, GE HealthCare Technologies Inc. (GEHC) is the stronger overall head-to-head candidate over Butterfly Network, Inc. Redeemable Warrants, each whole warrant exercisable for one share of (BFLY.WS) in the Tradestie Institutional Equity Comparison Engine, winning 10–0 core matrix metrics and 6–0 across our 6-pillar institutional scorecard (led by Valuation Multiples, Growth & Scale, Profitability & Quality). BFLY.WS carries a Unified Composite Score of 33.5/100 (SELL) at $0.01 (N/M Forward P/E, N/A operating margin), whereas GEHC carries 38.6/100 (SELL) at $80.64 (14.7x Forward P/E, 13.8% operating margin).

  • Defensive Composite Rating Caution: Although GEHC compares more favorably head-to-head, both BFLY.WS (33.5/100 SELL) and GEHC (38.6/100 SELL) currently screen in defensive SELL territory (<42/100) on our Unified Composite model.

Executive Snapshot Side-by-Side Composite Ratings & Technical Regime

Ask Alpha AI About BFLY.WS vs GEHC
BFLY.WS NYSE
Butterfly Network, Inc. Redeemable Warrants, each whole warrant exercisable for one share of Class A common stock, each at an exercise price of $11.50 per share
X-Ray Apparatus & Tubes & Related Irradiation Apparatus
$0.01
-50.0% 1D
Market Cap N/A
TTM Revenue N/A
Forward P/E N/M
Beta / 30D Vol 1.95β · 347% Vol
Unified Composite Score
33.5 / 100 SELL
Tech 25.0 Fund 40.0 Flow 50.0 Mom 50.0
Weinstein Technical Phase Neutral · Hold
Trend telemetry aligned with daily close.
RSI-14: N/A · SMA20: N/A · SMA50: N/A
GEHC NASDAQ Head-to-Head Winner
GE HealthCare Technologies Inc. Common Stock
X-Ray Apparatus & Tubes & Related Irradiation Apparatus
$80.64
-1.53% 1D
Market Cap $37.0B
TTM Revenue $21.6B
Forward P/E 14.7x
Beta / 30D Vol 0.52β · 39% Vol
Unified Composite Score
38.6 / 100 SELL
Tech 29.0 Fund 44.0 Flow 59.0 Mom 50.0
Weinstein Technical Phase Markup · Hold / add on dips
Price above SMA50, rising 50-day trend (5.6% over 20 days), RSI 56
RSI-14: 56.4 · SMA20: $80.51 · SMA50: $72.19

6-Pillar Scorecard Institutional Category Breakdown (BFLY.WS 0 – 6 GEHC)

Columns: Metric · BFLY.WS · GEHC
1. Valuation Multiples GEHC
Forward P/E N/M 14.7x
Trailing P/E N/M 17.3x
PEG Ratio N/M 2.24x
EV / Revenue N/M 2.1x
2. Growth & Scale GEHC
Revenue Growth (YoY) N/A +7.2%
Earnings Growth (YoY) N/A +39.0%
TTM Revenue (USD) N/A $21.6B
Market Cap N/A $37.0B
3. Profitability & Quality GEHC
Gross Margin N/A 39.3%
Operating Margin N/A 13.8%
Net Profit Margin N/A 10.0%
Return on Equity (ROE) N/A 20.0%
4. Balance Sheet & Cash Flow GEHC
Cash Generation (TTM) N/A $1.89B
Cash Flow Margin N/A 8.7%
Net Cash / Leverage N/A ROE $7.58B Net Debt (0.90x D/E)
Dividend Yield None (0.00%) 0.17%
5. Options & Positioning GEHC
Options Structure Phase UNCLASSIFIED SURGE
Current IV / %ile N/A (N/A) 58.6% (8th %ile)
Put/Call OI Skew N/A 0.28x (Call-Skewed)
OBV Trend / Tech Phase NEUTRAL · Neutral DISTRIBUTION · Markup
6. R&D & Supply-Chain Moat GEHC
OpEx & R&D Intensity N/A 25.5% of Rev ($5.52B)
90D R&D Disclosures 0 papers 0 papers
Competitive Moat Cyclical / Execution-Driven Positioning Scale & Operating Efficiency Moat
Supply-Chain Role X-Ray Apparatus & Tubes & Related Irradiation Apparatus Operator Medical Devices Operator

Core Matrix Head-to-Head Valuation, Margin, Cash Flow & Risk Table

Core Matrix Wins: BFLY.WS (0) vs GEHC (10)
Institutional Metric BFLY.WS GEHC Criterion Row Edge
Market Capitalization
Scale
N/A $37.0B Larger Scale GEHC
Trailing P/E Ratio
Valuation
N/M 17.3x Lower Multiple GEHC
Forward P/E Ratio
Valuation
N/M 14.7x Lower Multiple GEHC
Revenue Growth (YoY)
Growth
N/A +7.2% Higher Growth GEHC
Operating Margin (TTM)
Profitability
N/A 13.8% Higher Margin GEHC
Net Profit Margin
Profitability
N/A 10.0% Higher Margin GEHC
Return on Equity (ROE)
Capital Efficiency
N/A 20.0% Higher ROE GEHC
52-Week Range Position
Momentum
0% ($0–$0) 71% ($59–$90) Stronger Trend GEHC
Beta / 30D Volatility
Risk Regime
1.95β · 347% Vol 0.52β · 39% Vol Lower Realized Risk GEHC
Unified Institutional Score
Composite Signal
33.5 / 100 (SELL) 38.6 / 100 (SELL) Higher Composite GEHC
Trailing 12M Revenue (USD)
Operating Scale
N/A $21.6B FX-Normalized USD Scale
Gross Profit Margin (TTM)
Unit Pricing Power
N/A 39.3% Higher Margin Quality
PEG Ratio & EV / Revenue
Growth-Adjusted Valuation
N/M PEG · N/M EV/Rev 2.24x PEG · 2.1x EV/Rev Lower Multiple Valuation
Cash Flow & Balance Sheet
Capital Self-Funding
N/A (N/A ROE) $1.89B ($7.58B Net Debt (0.90x D/E)) Higher Cash / Net Cash Solvency

Momentum Normalized Relative Price Performance (1M · 3M · 6M · 1Y)

1M Horizon GEHC +68.4 pp
BFLY.WS: -69.89% · GEHC: -1.49%
3M Horizon GEHC +90.36 pp
BFLY.WS: -76.96% · GEHC: +13.4%
6M Horizon GEHC +90.36 pp
BFLY.WS: -76.96% · GEHC: +13.4%
1Y Horizon GEHC +90.36 pp
BFLY.WS: -76.96% · GEHC: +13.4%

Financial Trajectory Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant USD Revenue & Operating Margin (%)

Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on BFLY.WS vs GEHC. Trailing 12-month operating profitability (BFLY.WS N/A vs GEHC 13.8%) and valuation multiples (BFLY.WS N/M vs GEHC 14.7x Forward P/E) are benchmarked directly in Pillar 4 below.

BFLY.WS ADR TTM Benchmark FX-Normalized USD
TTM RevenueN/A
Gross MarginN/A
Op. MarginN/A
ROE / Fwd P/EN/A · N/M
GEHC ADR TTM Benchmark FX-Normalized USD
TTM Revenue$21.6B
Gross Margin39.3%
Op. Margin13.8%
ROE / Fwd P/E20.0% · 14.7x

Options Positioning Implied Volatility, Put/Call Skew & Dealer Gamma Corridor

Live Options Phase Tracker
BFLY.WS UNCLASSIFIED
0d in phase · OBV NEUTRAL
Current IV N/A
IV Percentile N/A
Put/Call OI Skew N/A
IV Regime Unclassified
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal NEUTRAL
OBV Flow NEUTRAL
Exact BFLY.WS Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →
GEHC SURGE
12d in phase · OBV DISTRIBUTION
Current IV 58.6%
IV Percentile 8th %ile
Put/Call OI Skew 0.28x (Call-Skewed)
IV Regime Compressed (<25th %ile)
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal BULLISH
OBV Flow DISTRIBUTION
Exact GEHC Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →
LIVE OPTIONS CHAIN · T+5 TRADING DAY HORIZON Spot $82.96 · IV 29.7%

GEHC Simulated 5-Day Option Payoffs vs. Owning 100 Shares ($8,296)

Compare $8,296 in 100-share capital outlay against risk-defined 5-day vertical spreads, put-wall income, and 3-leg structures at 29.7% ATM IV.

5-DAY BULLISH SWING Liq B

Dec 18 $82.5 / $87.5 Bull Call Spread

Buy 1x $82.5C · Sell 1x $87.5C · 32d

Net Entry $222 Debit
T+5d @ +5% Move +$109 (+49%)
Max Risk / Buffer $222 Capped
5d Edge & Liquidity 0.8x R:R · Liq B
Simulate 5-Day Payoff →
PUT-WALL MONTHLY INCOME Liq B

Dec 18 $77.5 / $72.5 Bull Put Spread

Sell 1x $77.5P · Buy 1x $72.5P · 32d

Net Entry $87 Credit
Max Credit / Yield +$87 (+21.1% RoM)
Max Risk / Buffer -7.6% Cushion ($413 Mgn)
5d Edge & Liquidity 78% PoP · Liq B
Simulate 5-Day Payoff →

Simulated T+5 trading day payoffs use live option midpoints, bid-ask spread adjustments, and implied volatility skew for educational scenario modeling only — not personalized investment advice. Options involve substantial risk.

Moat & R&D Supply-Chain Positioning, Bottleneck Moat & R&D Velocity

Corporate R&D & Foundry Leaderboard
BFLY.WS Moat Profile Cyclical / Execution-Driven Positioning
X-Ray Apparatus & Tubes & Related Irradiation Apparatus Operator
Competes within the X-Ray Apparatus & Tubes & Related Irradiation Apparatus value chain with N/A market capitalization and N/A operating margin.
OpEx & R&D Reinvestment N/A
90D Engineering Disclosures 0 Published
GEHC Moat Profile Scale & Operating Efficiency Moat
Medical Devices Operator
Competes within the Medical Devices value chain with $37.0B market capitalization and 13.8% operating margin.
OpEx & R&D Reinvestment 25.5% of Rev ($5.52B)
90D Engineering Disclosures 0 Published

Investor FAQ BFLY.WS vs GEHC Key Questions & Quantitative Answers

As of Nov 20, 2026, GE HealthCare Technologies Inc. (GEHC) is the stronger overall head-to-head candidate over Butterfly Network, Inc. Redeemable Warrants, each whole warrant exercisable for one share of (BFLY.WS) in the Tradestie Institutional Equity Comparison Engine, winning 10–0 core matrix metrics and 6–0 across our 6-pillar institutional scorecard (led by Valuation Multiples, Growth & Scale, Profitability & Quality). BFLY.WS carries a Unified Composite Score of 33.5/100 (SELL) at $0.01 (N/M Forward P/E, N/A operating margin), whereas GEHC carries 38.6/100 (SELL) at $80.64 (14.7x Forward P/E, 13.8% operating margin). Defensive Composite Rating Caution: Although GEHC compares more favorably head-to-head, both BFLY.WS (33.5/100 SELL) and GEHC (38.6/100 SELL) currently screen in defensive SELL territory (<42/100) on our Unified Composite model.

GEHC leads the Growth & Scale pillar: BFLY.WS posts N/A YoY revenue growth and N/A YoY earnings growth on N/A TTM revenue (N/A gross margin, N/A operating margin), compared with GEHC at +7.2% YoY revenue growth and +39.0% YoY earnings growth on $21.6B TTM revenue (39.3% gross margin, 13.8% operating margin). On trailing 12-month operating scale, BFLY.WS generates N/A in USD-normalized revenue versus $21.6B for GEHC. In operating R&D and SG&A reinvestment, BFLY.WS deploys N/A (0 90-day corporate R&D disclosures) versus 25.5% of Rev ($5.52B) (0 disclosures) for GEHC.

GEHC screens cheaper on headline valuation multiples. BFLY.WS trades at N/M Forward P/E, N/M Trailing P/E, N/M PEG, and N/M EV/Revenue (unreported cash flow margin), whereas GEHC trades at 14.7x Forward P/E, 17.3x Trailing P/E, 2.24x PEG, and 2.1x EV/Revenue (8.7% FCF margin). Multiples above 150x or negative earnings denominators are marked N/M to avoid distorted accounting comparisons; weigh lower Forward P/E and PEG against BFLY.WS (N/A ROE) versus GEHC (20.0% ROE) capital efficiency.

In options market volatility and institutional positioning, BFLY.WS carries N/A implied volatility (N/A, Unclassified), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (1.95β · 347% Vol realized risk). By comparison, GEHC carries 58.6% implied volatility (8th %ile, Compressed (<25th %ile)), a 0.28x (Call-Skewed) Put/Call open-interest ratio, DISTRIBUTION on-balance volume, and sits in a SURGE options structure phase (0.52β · 39% Vol realized risk).

Cross-Compare 1-Click Peer Rivalries & Single-Stock Research

Launch Custom Ticker Comparison →

Butterfly Network, Inc. Redeemable Warrants, each whole warrant exercisable for one share of Class A common stock, each at an exercise price of $11.50 per share (BFLY.WS) Research Suite

Powered by Tradestie Institutional Equity Comparison Engine & standardized corporate financial telemetry. Market close as of Nov 20, 2026. For educational research only; not investment advice.